Troutman Pepper Hamilton Sanders advised Palvella Therapeutics, Inc. on the deal. Palvella Therapeutics, Inc., a late clinical-stage biopharmaceutical company, announced the initial closing of its Series...
This content is for Standard 1 Year members only. LoginJoin Now